Inventor · disambiguated record
Ian Foltz
Also filed as: FOLTZ IAN · FOLTZ IAN N · FOLTZ IAN NEVIN
67 granted patents·29 pending applications·1,557 citations·filing 2002–2025
99Inventor score
Top patents by PatentIndex Score
96 records- 0198US7326414B2Antibodies to M-CSFWARNER LAMBERT CO·Filed 2006·Granted Feb 5, 2008·86 cites·66 claims
- 0297US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0397US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0495US9493565B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2014·Granted Nov 15, 2016·50 cites·8 claims
- 0595US8779108B2Targeted binding agents against B7-H1QUEVA CHRISTOPHE·Filed 2010·Granted Jul 15, 2014·452 cites·31 claims
- 0695US7521048B2TRAIL receptor-2 polypeptides and antibodiesAMGEN INC·Filed 2006·Granted Apr 21, 2009·172 cites·37 claims
- 0794US9464139B2GITR antigen binding proteins and methods of use thereofAMGEN INC·Filed 2014·Granted Oct 11, 2016·57 cites·28 claims
- 0894US8444981B2Alpha-4 beta-7 heterodimer specific antagonist antibodyHSU HAILING·Filed 2010·Granted May 21, 2013·14 cites·36 claims
- 0994US7728113B2Methods of treating arthritic conditions with antibodies to M-CSFAMGEN FREMONT INC·Filed 2007·Granted Jun 1, 2010·21 cites·27 claims
- 1094US7585500B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2005·Granted Sep 8, 2009·36 cites·3 claims
- 1193US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 1293US7378091B2Antibodies against carbonic anhydrase IX (CA IX) tumor antigenAMGEN FREMONT INC·Filed 2002·Granted May 27, 2008·44 cites·25 claims
- 1392US10851144B2Interleukin-2 muteins for the expansion of T-regulatory cellsAMGEN INC·Filed 2016·Granted Dec 1, 2020·16 cites·10 claims
- 1491US11541103B2Interleukin-21 mutein/ anti-PD-1 antibody conjugatesAMGEN INC·Filed 2018·Granted Jan 3, 2023·7 cites·34 claims
- 1591US10294303B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2016·Granted May 21, 2019·12 cites·14 claims
- 1691US8192738B2Targeted antibodies directed to DLL4BEDIAN VAHE·Filed 2009·Granted Jun 5, 2012·16 cites·21 claims
- 1790US10400039B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2016·Granted Sep 3, 2019·8 cites·8 claims
- 1890US9382318B2ST2 antigen binding proteinsAMGEN INC·Filed 2013·Granted Jul 5, 2016·10 cites·29 claims
- 1990US9315577B2Anti-hepcidin antibodies and methods of useFOLTZ IAN·Filed 2009·Granted Apr 19, 2016·24 cites·2 claims
- 2090US8858942B2Antibodies directed to ERBB2MEDIMMUNE LTD·Filed 2012·Granted Oct 14, 2014·11 cites·12 claims
- 2190US7318925B2Methods of use for antibodies against parathyroid hormoneAMGEN FREMONT INC·Filed 2004·Granted Jan 15, 2008·30 cites·27 claims
- 2290US7288253B2Antibodies directed to parathyroid hormone (PTH) and uses thereofAMGEN FREMONT INC·Filed 2003·Granted Oct 30, 2007·32 cites·16 claims
- 2389US11186636B2Anti-human TREM2 antibodies and uses thereofAMGEN INC·Filed 2018·Granted Nov 30, 2021·12 cites·17 claims
- 2489US8454962B2Alpha-4-beta-7 heterodimer specific antagonist antibodyHSU HAILING·Filed 2012·Granted Jun 4, 2013·5 cites·36 claims
- 2589US8350011B2Antibodies to ErbB2MEDIMMUNE LTD·Filed 2007·Granted Jan 8, 2013·10 cites·7 claims
- 2689US7592430B2Antibodies to M-CSFAMGEN FREMONT·Filed 2004·Granted Sep 22, 2009·22 cites·52 claims
- 2789US2025163160A1Human Antigen Binding Proteins That Bind Beta-Klotho, FGF Receptors and Complexes ThereofAMGEN INC·Filed 2024·Application pending·0 cites
- 2888US11059895B2ST2 antigen binding proteinsAMGEN INC·Filed 2019·Granted Jul 13, 2021·2 cites·38 claims
- 2988US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 3088US7265212B2Anti-CD45RB antibodiesAMGEN FREMONT INC·Filed 2002·Granted Sep 4, 2007·33 cites·8 claims
- 3188US2024368292A1St2 antigen binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 3287US11518808B2Anti-PD-1 antibodies and methods of treatmentAMGEN INC·Filed 2019·Granted Dec 6, 2022·5 cites·21 claims
- 3387US9982054B2ST2 antigen binding proteinsAMGEN INC·Filed 2016·Granted May 29, 2018·4 cites·34 claims
- 3487US8067544B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2004·Granted Nov 29, 2011·37 cites·18 claims
- 3586US12252540B2Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Mar 18, 2025·1 cites·5 claims
- 3686US11046774B2Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonistsAMGEN INC·Filed 2019·Granted Jun 29, 2021·5 cites·18 claims
- 3786US9499620B2Methods of using an alpha-4-beta-7 heterodimer specific antagonist antibodyAMGEN INC·Filed 2014·Granted Nov 22, 2016·5 cites·8 claims
- 3886US9284378B2Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereofHU SHAW-FEN SYLVIA·Filed 2010·Granted Mar 15, 2016·9 cites·3 claims
- 3986US7994302B2Fully human monoclonal antibodies to IL-13AMGEN INC·Filed 2009·Granted Aug 9, 2011·8 cites·8 claims
- 4085US8871490B2Alpha-4-beta-7 heterodimer specific antagonist antibodyHSU HAILING·Filed 2013·Granted Oct 28, 2014·5 cites·14 claims
- 4185US8454961B2Alpha-4-beta-7 heterodimer specific antagonist antibodyHSU HAILING·Filed 2012·Granted Jun 4, 2013·5 cites·36 claims
- 4285US8398975B2Antibodies directed to αVβ6 and uses thereofRINKENBERGER JULIE·Filed 2010·Granted Mar 19, 2013·15 cites·9 claims
- 4385US7572444B2Binding proteins specific for human matriptaseAMGEN FREMONT INC·Filed 2005·Granted Aug 11, 2009·12 cites·17 claims
- 4484US9517264B2Human FGF receptor and β-Klotho binding proteinsFACHINI ROGER·Filed 2011·Granted Dec 13, 2016·19 cites·41 claims
- 4583US7754859B2Targeted binding agents directed to PDGFR-alpha and uses thereofASTRAZENECA AB·Filed 2007·Granted Jul 13, 2010·7 cites·18 claims
- 4682US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 4781US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 4881US11248052B2Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorAMGEN INC·Filed 2019·Granted Feb 15, 2022·1 cites·5 claims
- 4981US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 5080US9085624B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jul 21, 2015·2 cites·26 claims
Showing the top 50 of 96 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →